{"prompt": "['2017N323364_0', 'CONFIDENTIAL', '2019N398531_00', '207626', 'Jones P, Harding G, Berry P, Wiklund I, Chen W-H, Leidy N. Development and first', 'validation of the COPD Assessment Test (CAT) Eur Respir J 2009; 34: 648-654', 'Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy N. \"Tests of the', 'Responsiveness of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test', '(CAT) Following Acute Exacerbation and Pulmonary Rehabilitation. Chest 2012; 142:', '134-140', 'Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, et al. Comparison of tiotropium', 'plus fluticasone propionate/salmeterol with tiotropium in COPD: A randomized', 'controlled study. Resp Med 2012; 106: 382-389', 'Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism, and', 'osteoporosis. Chest. 2011;139:648-657.', 'Lipson DA, Barnacle H, Birk R, Brealey N, Locantore N, Lomas DA, et al. FULFIL', 'Trial: Once-Daily Triple Therapy in Patients with Chronic Obstructive Pulmonary', 'Disease. Am J Respir Crit Care Med 2017;10.1164/rccm.201703-04490C. [Epub ahead', 'of print]', 'Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an', 'improved COPD-Specific Version of the St. George Respiratory Questionnaire. Chest', '2007;132:456-463.', 'Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.', 'Standardisation of spirometry. Eur Respir J. 2005;26:319-338.', 'Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy 2014;69:1582', '1587.', 'Packe GE, Cayton RM, Mashhoudi N. Nebulised ipratropium bromide and salbutamol', 'causing closed-angle glaucoma. Lancet 1984;2:691.', 'Quanjer P, Stanojevic S, Cole T, Baur X, Hall G, Culver, BH, et al. Multi-ethnic', 'reference values for spirometry for the 3-95-yr age range: The global lung function 2012', 'equations. Eur Respi J 2012; 40: 1324-1343.', 'Sharafkhaneh A, Southard JG, Goldman M, Uryniak T, Martin UJ. Effect of', 'budesonide/formorterol pMDI on COPD exacerbations: A double-blind, randomized', 'study. Respir Med 2012;106:257-268.', 'Siler TM, Kerwin E, Sousa AR, Donald A, Ali R, Church A. Efficacy and safety of', 'umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary', 'disease: results of two randomized studies. Respir Med. 2015; 109: 1155-1163.', 'Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al A 4-year Trial of', 'Tiotropium in Chronic Obstructive Pulmonary Disease. N Engl J Med 2008; 359:1543-', '1554.', '76']['2017N323364_0', 'CONFIDENTIAL', '2019N398531_00', '207626', 'Weldon D. The effects of corticosteroids on bone growth and bone density. Ann. Allergy', 'Asthma Immunol. 2009;103:3-11.', 'Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al.', 'Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients', 'with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2009;', '180:741-750.', \"Wolters Kluwer's Source Lx Database Hierarchical Regimen Analysis (HRA)\", 'Application SLED Report With Filtering On Patients Aged 18+ With COPD Only. Data', 'from February 2011 through January 2012.', 'Wurst KE, Bushnell G, Shukla A, Muellerova H, Davis KJ. Factors Associated with', 'Time to Triple Therapy in Newly Diagnosed COPD Patients in the UK General Practice', 'Research Database. (2013) 29th International Conference on Pharmacoepidemiology and', 'Therapeutic Risk Management, Montreal, Canada (August 25-28, 2013). Abstract 62.', '77']\n\n###\n\n", "completion": "END"}